ArticleTheranostics2021

Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.

Xin Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.